REGENXBIO ($RGNX) posted quarterly earnings results on Monday, May 12th. The company reported earnings of $0.12 per share, missing estimates of $0.49 by $0.37. The company also reported revenue of $89,010,000, missing estimates of $104,008,125 by $-14,998,125.
You can see Quiver Quantitative's $RGNX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
REGENXBIO Hedge Fund Activity
We have seen 89 institutional investors add shares of REGENXBIO stock to their portfolio, and 105 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 1,061,187 shares (+406.3%) to their portfolio in Q4 2024, for an estimated $8,202,975
- MORGAN STANLEY added 653,435 shares (+48.4%) to their portfolio in Q4 2024, for an estimated $5,051,052
- AVIDITY PARTNERS MANAGEMENT LP removed 600,564 shares (-53.0%) from their portfolio in Q4 2024, for an estimated $4,642,359
- STATE STREET CORP removed 597,032 shares (-21.5%) from their portfolio in Q4 2024, for an estimated $4,615,057
- AQUILO CAPITAL MANAGEMENT, LLC removed 584,406 shares (-62.8%) from their portfolio in Q4 2024, for an estimated $4,517,458
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 500,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $3,865,000
- VANGUARD GROUP INC added 487,036 shares (+16.3%) to their portfolio in Q1 2025, for an estimated $3,482,307
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
REGENXBIO Analyst Ratings
Wall Street analysts have issued reports on $RGNX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 01/07/2025
- Raymond James issued a "Outperform" rating on 11/18/2024
To track analyst ratings and price targets for REGENXBIO, check out Quiver Quantitative's $RGNX forecast page.
REGENXBIO Price Targets
Multiple analysts have issued price targets for $RGNX recently. We have seen 2 analysts offer price targets for $RGNX in the last 6 months, with a median target of $26.0.
Here are some recent targets:
- Luca Issi from RBC Capital set a target price of $30.0 on 01/07/2025
- Judah Frommer from Morgan Stanley set a target price of $22.0 on 11/15/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
